| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1553.92 | 97 |
| GSM780708 | Untreated after 4 days (C2_1) | 1769.41 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 2193.02 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 1549.53 | 97 |
| GSM780720 | Untreated after 4 days (C2_2) | 1672.62 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 2165.84 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1989.85 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1643.56 | 97 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1475.56 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1949.83 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1608.52 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1615.8 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1583.31 | 97 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1745.15 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1742.61 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1835.17 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1897.68 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1797.71 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1972.59 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1913.39 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1663.16 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2047.73 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1856.45 | 98 |